Tumor-Associated and Systemic Autoimmunity in Pre-Clinical Breast Cancer among Post-Menopausal Women
Autoantibodies to tumor-associated antigens (anti-TAA) are potential biomarkers for breast cancer, but their relationship systemic autoimmunity as ascertained though antinuclear antibodies (ANA) is unknown and warrants consideration given the common occurrence of autoimmunity and autoimmune diseases...
Main Authors: | Christine G. Parks, Lauren E. Wilson, Michela Capello, Kevin D. Deane, Samir M. Hanash |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/11/1566 |
Similar Items
-
Investigation of autoantibodies to soluble, onconeural or transmembrane autoantigens in patients with autoimmune-mediated neurological diseases
by: Chang, P-S
Published: (2022) -
AT1‐AA Is Produced in Offspring in Response to Placental Ischemia and Is Lowered by B‐Cell Depletion Without Compromising Overall Offspring Health
by: Nathan Campbell, et al.
Published: (2024-02-01) -
Autoantibodies as biomarkers for breast cancer diagnosis and prognosis
by: Ruozhu Yang, et al.
Published: (2022-11-01) -
The Association of Thyroid Autoimmunity and Lipid Profile in Hypothyroidism: A Cross-sectional Study
by: Itisha Katha, et al.
Published: (2023-12-01) -
Biosensing for Autoimmune Chronic Disease—A Review
by: Rebecca Golfinopoulou, et al.
Published: (2023-06-01)